Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Recommendation of "Hold" from Brokerages

Key Points

• Consensus "Hold": Seven brokerages rate Pediatrix Medical Group a consensus "Hold" (five holds, two buys) with an average 1‑year price target of $21.33 and analyst targets ranging up to $27 (Jefferies).
• Notable institutional activity: Wasatch Advisors opened a new position worth about $43.86M and overall institutional ownership is very high at 97.71%, with several other managers adding to stakes.
• Recent results and valuation: Shares trade around $23.39 (52‑week range $11.84–$24.99) with a $1.94B market cap and 12.06 P/E; last quarter reported EPS of $0.50 (miss) and revenue of $493.8M (beat).

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have earned a consensus rating of "Hold" from the seven brokerages that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $21.3333.

MD has been the subject of a number of recent research reports. UBS Group cut their price objective on Pediatrix Medical Group from $23.00 to $22.00 and set a "neutral" rating for the company in a research note on Tuesday, February 24th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Pediatrix Medical Group in a research note on Friday, March 27th. Zacks Research downgraded Pediatrix Medical Group from a "strong-buy" rating to a "hold" rating in a research note on Friday, January 23rd. Truist Financial upped their price target on Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a "hold" rating in a research note on Monday, April 13th. Finally, Jefferies Financial Group restated a "buy" rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research note on Monday, April 20th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Strs Ohio boosted its stake in Pediatrix Medical Group by 6.5% in the 1st quarter. Strs Ohio now owns 41,100 shares of the company's stock worth $879,000 after purchasing an additional 2,500 shares during the period. Keybank National Association OH boosted its stake in Pediatrix Medical Group by 2.0% in the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company's stock worth $491,000 after purchasing an additional 458 shares during the period. Wasatch Advisors LP bought a new position in Pediatrix Medical Group in the 1st quarter worth approximately $43,861,000. Louisiana State Employees Retirement System bought a new position in Pediatrix Medical Group in the 1st quarter worth approximately $798,000. Finally, Ritholtz Wealth Management boosted its stake in Pediatrix Medical Group by 42.1% in the 1st quarter. Ritholtz Wealth Management now owns 143,668 shares of the company's stock worth $3,073,000 after purchasing an additional 42,553 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Trading Up 1.5%

Pediatrix Medical Group stock opened at $23.39 on Tuesday. The business has a 50-day simple moving average of $20.87 and a two-hundred day simple moving average of $21.07. The company has a market cap of $1.94 billion, a P/E ratio of 12.06 and a beta of 0.72. Pediatrix Medical Group has a 52-week low of $11.84 and a 52-week high of $24.99. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.66.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Thursday, February 19th. The company reported $0.50 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.53 by ($0.03). The company had revenue of $493.77 million for the quarter, compared to the consensus estimate of $486.23 million. Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The company's revenue was down 1.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.51 earnings per share. Analysts predict that Pediatrix Medical Group will post 2.05 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.